Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration

被引：8

作者：

Mussolin, Lara ^{[1
,2
]}

Lovisa, Federica ^{[1
,2
]}

Gallingani, Ilaria ^{[1
]}

Cavallaro, Elena ^{[1
]}

Carraro, Elisa ^{[1
]}

Damanti, Carlotta C. ^{[1
]}

Vinti, Luciana ^{[3
]}

Sala, Alessandra ^{[4
]}

Micalizzi, Concetta ^{[5
]}

Santoro, Nicola ^{[6
]}

Piglione, Matilde ^{[7
]}

Cellini, Monica ^{[8
]}

Buffardi, Salvatore ^{[9
]}

Buldini, Barbara ^{[1
]}

D'Amore, Emanuele S. G. ^{[10
]}

Biffi, Alessandra ^{[1
,2
,11
]}

Pillon, Marta ^{[1
]}

机构：

[1] Univ Padua, Div Pediat Hematol Oncol & Stem Cell Transplant, Dept Women & Child Hlth, Padua, Italy

[2] Ist Ric Pediat Citta Speranza, Padua, Italy

[3] Bambino Gesu Pediat Hosp, Dept Pediat Hematooncol, Rome, Italy

[4] Univ Milano Bicocca, Dept Paediat, Fdn MBBM, Azienda Osped S Gerardo, Monza, Italy

[5] IRCCS Ist Giannina Gaslini, Dept Paediat Haematooncol, Genoa, Italy

[6] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy

[7] Univ Hosp Citta Salute & Sci Torino, Dept Paediat, Paediat Haematol, Turin, Italy

[8] Policlin Hosp, Div Paediat Oncol Haematol, Modena, Italy

[9] Santobono Pausilipon Childrens Hosp, Dept Paediat Haematooncol, Naples, Italy

[10] San Bortolo Hosp, Dept Pathol, Vicenza, Italy

[11] Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 03期

关键词：

B-cell acute leukaemia; Burkitt; AIEOP LNH-97; anti-CD20; paediatric; minimal residual disease; NON-HODGKIN-LYMPHOMA; ACUTE-LYMPHOBLASTIC-LEUKEMIA; CHILDREN; ADOLESCENTS; RITUXIMAB; BURKITT; CHEMOTHERAPY; LYMPHOMA/LEUKAEMIA; INTERMEDIATE; THERAPY;

D O I：

10.1111/bjh.16531

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E108 / E111

页数：4

共 32 条

[1] Minimal disseminated and minimal residual disease study in Burkitt lymphoma patients treated according to AIEOP LNH-97 protocol and anti-CD20
Mussolin, L.
Lovisa, F.
Carraro, E.
Gallingani, I.
Vinti, L.
Buffardi, S.
Piglione, M.
Tondo, A.
Garaventa, A.
Sala, A.
Giraldi, E.
Pierani, P.
Mura, R.
Basso, G.
Pillon, M.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 82 - 82
[2] Good outcome of patients with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) treated with the protocol AIEOP LNH-97
Mussolin, L.
Carraro, E.
d'Amore, E.
Tondo, A.
Garaventa, A.
Lovisa, F.
Piglione, M.
Sala, A.
Buffardi, S.
Perruccio, K.
Mura, R.
Lo Nigro, L.
Zanazzo, G.
Vinti, A.
Melchionda, F.
D'Angelo, P.
Sperli, D.
Consarino, C.
Moleti, Ml
Mura, R.
Arico, M.
Santoro, N.
Basso, G.
Pillon, M.
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 33 - 33
[3] Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol
Pillon, Marta
Mussolin, Lara
Carraro, Elisa
Conter, Valentino
Arico, Maurizio
Vinti, Luciana
Garaventa, Alberto
Piglione, Matilde
Buffardi, Salvatore
Sala, Alessandra
Santoro, Nicola
Lo Nigro, Luca
Mura, Rossella
Tondo, Annalisa
Casale, Fiorina
Farruggia, Piero
Pierani, Paolo
Cesaro, Simone
d'Amore, Emanuele S. G.
Basso, Giuseppe
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (03) : 467 - 475
[4] Outcome of acute B-cell lymphoblastic leukemia of childhood treated with ALEOP LNH-97 protocol
Pillon, M.
Mussolin, L.
Carraro, E.
Garaventa, A.
Sala, A.
Lombardi, A.
Arico, M.
Piglione, M.
Giraldi, E.
Buffardi, S.
Zecca, M.
Porta, F.
Zanazzo, G.
Cellini, M.
Pession, A.
Arcamone, G. P.
Lo Nigro, L.
Sperli, D.
Casale, F.
Basso, G.
Rosolen, A.
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 45 - 45
[5] Application of the international pediatric Non-Hodgkin lymphoma staging system (IPNHLSS) to pediatric patients newly diagnosed with B-cell Non-Hodgkin's lymphoma (B-NHL) enrolled in the AIEOP LNH-97 protocol
Onofrillo, Daniela
Pascale, Silvia
Carraro, Elisa
Massano, Davide
Mussolin, Lara
Mura, Rosamaria
Vinti, Luciana
Buffardi, Salvatore
Farruggia, Piero
Cesaro, Simone
Tolva, Alessandra
Bertolini, Patrizia
Piglione, Matilde
Tondo, Annalisa
Santoro, Nicola
Garaventa, Alberto
Lo Nigro, Luca
Sala, Alessandra
Pillon, Marta
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 39 - 40
[6] Anti-CD20 monoclonal antibody (Mabthera®) administration post chlorambucil in mantle cell lymphoma (MCL) patients leads to eradication of minimal residual disease.
Dimopoulou, MN
Siakantaris, MP
Kontopidou, FN
Angelopoulou, MK
Doussis-Anagnostopoulou, IA
Korkolopoulou, P
Kittas, C
Pangalis, GA
BLOOD, 2000, 96 (11) : 236B - 236B
[7] MINIMAL RESIDUAL DISEASE AND B-CELL SUBPOPULATION MONITORING IN ACUTE B-LYMPHOBLASTIC LEUKAEMIA PATIENTS TREATED ON RALL-2016 PROTOCOL
Galtseva, I., V
Davydova, Y. O.
Parovichnikova, E. N.
Gavrilina, O. A.
Troitskaya, V. V.
Kapranov, N. M.
Nikiforova, K. A.
Isinova, G. A.
Zarubina, K., I
Sokolov, A. N.
Savchenko, V. G.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (02): : 192 - 205
[8] Rituximab (anti-CD20 monoclonal antibody) immunotherapy in patients with B-cell non-Hodgkin's lymphoma:: highly effective treatment of residual disease
Papajík, T
Szotkowski, T
Raida, L
Hubáek, J
Faber, E
Hlusí, A
Vondráková, J
Pikalová, Z
Jedliková, K
Jarosová, M
Indrák, K
LEUKEMIA, 2001, 15 (03) : 510 - 510
[9] Anti-CD20 Monoclonal Antibody Therapy and Minimal Residual Disease Status of T-Cell/Histiocyte-Rich Large B Cell Non-Hodgkin Lymphoma
Valera, Elvis Terci
Queiroz, Rosane Gomes
Brassesco, Maria Sol
Scrideli, Carlos Alberto
Neves, Fabia
Tone, Luiz Gonzaga
PEDIATRIC BLOOD & CANCER, 2011, 57 (02) : 348 - 349
[10] Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
Heinzerling, LM
Urbanek, M
Funk, JO
Peker, S
Bleck, O
Neuber, K
Burg, G
von den Driesch, P
Dummer, R
CANCER, 2000, 89 (08) : 1835 - 1844

← 1 2 3 4 →